Commentary on Dartois et al.--model building in population PK-PD analyses. A 2002-2004 literature survey
- PMID: 17764478
- PMCID: PMC2203264
- DOI: 10.1111/j.1365-2125.2007.02973.x
Commentary on Dartois et al.--model building in population PK-PD analyses. A 2002-2004 literature survey
Comment on
-
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Br J Clin Pharmacol. 2007 Nov;64(5):603-12. doi: 10.1111/j.1365-2125.2007.02975.x. Epub 2007 Aug 15. Br J Clin Pharmacol. 2007. PMID: 17711538 Free PMC article. Review.
Similar articles
-
[Using CTS and PK-PD models to predict the effect of uncertainty about population parameters on clinical trial power].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009 Feb;26(1):42-6, 62. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009. PMID: 19334551 Chinese.
-
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Br J Clin Pharmacol. 2007 Nov;64(5):603-12. doi: 10.1111/j.1365-2125.2007.02975.x. Epub 2007 Aug 15. Br J Clin Pharmacol. 2007. PMID: 17711538 Free PMC article. Review.
-
PK/PD modelling and simulations: utility in drug development.Drug Discov Today. 2008 Apr;13(7-8):341-6. doi: 10.1016/j.drudis.2008.01.003. Epub 2008 Mar 7. Drug Discov Today. 2008. PMID: 18405847 Review.
-
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.Drug Discov Today. 2009 Mar;14(5-6):316-20. doi: 10.1016/j.drudis.2008.11.004. Epub 2008 Dec 26. Drug Discov Today. 2009. PMID: 19059496 Review.
-
Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.Clin Pharmacol Ther. 2007 Jul;82(1):3-6. doi: 10.1038/sj.clpt.6100248. Clin Pharmacol Ther. 2007. PMID: 17571065 No abstract available.
References
-
- Dartois C, Brendel K, Comets E, Laffont C, Laveille C, Tranchand B, Mentre F, Lemenuel A, Girard P. Overview of model-building strategies in population PK/PD analyses: 2002–2004 literature survey. Br J Clin Pharmacol. 2007 Epub ahead of print. doi: 10.1111/j1365-2125.2007.02975.x. - DOI - PMC - PubMed
-
- Retout S, Mentré F. Optimisation of individual and population designs using Splus. J Pharmacokinet Pharmacodyn. 2003;30:417–43. - PubMed
-
- Duffull SB, Mentre F, Aarons L. Optimal design of a population pharmacodynamic experiment for ivabradine. Pharm Res. 2001;18:83–9. - PubMed
-
- Sheiner LB, Steimer JL. Pharmacokinetic/pharmacodynamic modeling in drug development. Annu Rev Pharmacol Toxicol. 2000;40:67–95. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources